Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

1. Michels, S.
2. Massutí, B.
3. Schildhaus, H.-U.
4. Franklin, J.
5. Sebastian, M.
6. Felip, E.
7. Grohé, C.
8. Rodriguez-Abreu, D.
9. Abdulla, D.S.Y.
10. Bischoff, H.
11. Brandts, C.
12. Carcereny, E.
13. Corral, J.
14. Dingemans, A.-M.C.
15. Pereira, E.
16. Fassunke, J.
17. Fischer, R.N.
18. Gardizi, M.
19. Heukamp, L.
20. Insa, A.
21. Kron, A.
22. Menon, R.
23. Persigehl, T.
24. Reck, M.
25. Riedel, R.
26. Rothschild, S.I.
27. Scheel, A.H.
28. Scheffler, M.
29. Schmalz, P.
30. Smit, E.F.
31. Limburg, M.
32. Provencio, M.
33. Karachaliou, N.
34. Merkelbach-Bruse, S.
35. Hellmich, M.
36. Nogova, L.
37. Büttner, R.
38. Rosell, R.
39. Wolf, J.
40. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.JTHO.2019.03.020 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus